Idis Named Patient Programmes
- We're the world's leading consultant in developing, implementing and managing inspired solutions that meet the unmet medical needs of patients around the world
- These solutions are Idis Named Patient Programmes and they help healthcare professionals and patients access potentially life-saving drugs
- We partner with pharmaceutical and biotech companies to help them plan early access management strategies, to help their drugs transition to launch and beyond
Today's challenge
In our increasingly connected world, drugs are no longer hidden from the public until they’re launched and requests to pharmaceutical and biotech companies for developmental drugs are growing.
We partner with pharmaceutical and biotech companies, connecting them with pharmacists and physicians, to enable access to these drugs within responsible and ethical frameworks through Idis Named Patient Programmes.
Using these programmes, Idis develops and manages access to pre-approved products, helping connect the right patients to the right drugs.
To see how Idis Named Patient Programmes can help you create early access management strategies, please contact Simon Estcourt

